North America Injectable Anticoagulants Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Choose Licence

 

"The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]). In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism." Scope of the Report: This report focuses on the Injectable Anticoagulants in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Sanofi Genentech (Roche) Boehringer Ingelheim Pfizer The Medicines Company Aspen Otsuka Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Low-molecular-weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Other Market Segment by Applications, can be divided into VTE ACS/MI AF Other There are 15 Chapters to deeply display the North America Injectable Anticoagulants market. Chapter 1, to describe Injectable Anticoagulants Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Injectable Anticoagulants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Injectable Anticoagulants, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Injectable Anticoagulants market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Injectable Anticoagulants Research Findings and Conclusion, Appendix, methodology and data source

 

Table of Contents 1 Market Overview 1.1 Injectable Anticoagulants Introduction 1.2 Market Analysis by Type 1.2.1 Low-molecular-weight Heparin (LMWH) 1.2.2 Direct Thrombin Inhibitor (DTI) 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 VTE 1.3.2 ACS/MI 1.3.3 AF 1.3.4 Other 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Mexico Status and Prospect (2012-2022) 1.4.3 Canada Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Sanofi 2.1.1 Profile 2.1.2 Injectable Anticoagulants Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Sanofi News 2.2 Genentech (Roche) 2.2.1 Profile 2.2.2 Injectable Anticoagulants Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Genentech (Roche) News 2.3 Boehringer Ingelheim 2.3.1 Profile 2.3.2 Injectable Anticoagulants Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Boehringer Ingelheim News 2.4 Pfizer 2.4.1 Profile 2.4.2 Injectable Anticoagulants Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 Pfizer News 2.5 The Medicines Company 2.5.1 Profile 2.5.2 Injectable Anticoagulants Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.4 Business Overview 2.5.5 The Medicines Company News 2.6 Aspen 2.6.1 Profile 2.6.2 Injectable Anticoagulants Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.4 Business Overview 2.6.5 Aspen News 2.7 Otsuka 2.7.1 Profile 2.7.2 Injectable Anticoagulants Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7.4 Business Overview 2.7.5 Otsuka News 3 North America Injectable Anticoagulants Market Competition, by Manufacturer 3.1 North America Injectable Anticoagulants Sales and Market Share by Manufacturer (2016-2017) 3.2 North America Injectable Anticoagulants Revenue and Market Share by Manufacturer (2016-2017) 3.3 North America Injectable Anticoagulants Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Injectable Anticoagulants Manufacturer Market Share 3.4.2 Top 5 Injectable Anticoagulants Manufacturer Market Share 3.5 Market Competition Trend 4 North America Injectable Anticoagulants Market Analysis by Countries 4.1 North America Injectable Anticoagulants Sales Market Share by Countries 4.2 North America Injectable Anticoagulants Sales by Countries (2012-2017) 4.3 North America Injectable Anticoagulants Revenue (Value) by Countries (2012-2017) 5 North America Market Segmentation Injectable Anticoagulants by Type 5.1 North America Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017) 5.1.1 North America Injectable Anticoagulants Sales and Market Share by Type (2012-2017) 5.1.2 North America Injectable Anticoagulants Revenue and Market Share by Type (2012-2017) 5.2 Low-molecular-weight Heparin (LMWH) Sales Growth and Price 5.2.1 North America Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017) 5.2.2 North America Low-molecular-weight Heparin (LMWH) Price (2012-2017) 5.3 Direct Thrombin Inhibitor (DTI) Sales Growth and Price 5.3.1 North America Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017) 5.3.2 North America Direct Thrombin Inhibitor (DTI) Price (2012-2017) 5.4 Other Sales Growth and Price 5.4.1 North America Other Sales Growth (2012-2017) 5.4.2 North America Other Price (2012-2017) 6 North America Market Segmentation Injectable Anticoagulants by Application 6.1 North America Injectable Anticoagulants Sales Market Share by Application (2012-2017) 6.2 VTE Sales Growth (2012-2017) 6.3 ACS/MI Sales Growth (2012-2017) 6.4 AF Sales Growth (2012-2017) 6.5 Other Sales Growth (2012-2017) 7 United States Injectable Anticoagulants Sales, Revenue, by Type, Application and Manufacturers 7.1 United States Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017) 7.2 United States Injectable Anticoagulants Sales and Market Share by Type 7.3 United States Injectable Anticoagulants Sales by Application (2012-2017) 7.4 United States Injectable Anticoagulants Sales, Revenue and Market Share by Manufacturer 7.4.1 United States Injectable Anticoagulants Sales and Market Share by Manufacturer 7.4.2 United States Injectable Anticoagulants Revenue and Market Share by Manufacturer 7.5 United States Injectable Anticoagulants Export and Import (2012-2017) 8 Canada Injectable Anticoagulants Sales, Revenue, by Type, Application and Manufacturers 8.1 Canada Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017) 8.2 Canada Injectable Anticoagulants Sales and Market Share by Type 8.3 Canada Injectable Anticoagulants Sales by Application (2012-2017) 8.4 Canada Injectable Anticoagulants Sales, Revenue and Market Share by Manufacturer 8.4.1 Canada Injectable Anticoagulants Sales and Market Share by Manufacturer 8.4.2 Canada Injectable Anticoagulants Revenue and Market Share by Manufacturer 8.5 Canada Injectable Anticoagulants Export and Import (2012-2017) 9 Mexico Injectable Anticoagulants Sales, Revenue, by Type, Application and Manufacturers 9.1 Mexico Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017) 9.2 Mexico Injectable Anticoagulants Sales and Market Share by Type 9.3 Mexico Injectable Anticoagulants Sales by Application (2012-2017) 9.4 Mexico Injectable Anticoagulants Sales, Revenue and Market Share by Manufacturer 9.4.1 Mexico Injectable Anticoagulants Sales and Market Share by Manufacturer 9.4.2 Mexico Injectable Anticoagulants Revenue and Market Share by Manufacturer 9.5 Mexico Injectable Anticoagulants Export and Import (2012-2017) 10 Injectable Anticoagulants Market Forecast (2017-2022) 10.1 North America Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022) 10.2 Injectable Anticoagulants Market Forecast by Countries (2017-2022) 10.2.1 United States Injectable Anticoagulants Forecast (2017-2022) 10.2.2 Canada Injectable Anticoagulants Forecast (2017-2022) 10.2.3 Mexico Injectable Anticoagulants Forecast (2017-2022) 10.3 Injectable Anticoagulants Market Forecast by Type (2017-2022) 10.4 Injectable Anticoagulants Market Forecast by Application (2017-2022) 11 Injectable Anticoagulants Manufacturing Cost Analysis 11.1 Injectable Anticoagulants Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Injectable Anticoagulants 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Injectable Anticoagulants Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016 12.4 Downstream Buyers 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Injectable Anticoagulants Picture Table Product Specifications of Injectable Anticoagulants Figure North America Sales Market Share of Injectable Anticoagulants by Types in 2016 Table Types of Injectable Anticoagulants Figure Low-molecular-weight Heparin (LMWH) Picture Table Major Manufacturers of Low-molecular-weight Heparin (LMWH) Figure Direct Thrombin Inhibitor (DTI) Picture Table Major Manufacturers of Direct Thrombin Inhibitor (DTI) Figure Other Picture Table Major Manufacturers of Other Table North America Injectable Anticoagulants Sales Market Share by Applications in 2016 Table Applications of Injectable Anticoagulants Figure VTE Picture Figure ACS/MI Picture Figure AF Picture Figure Other Picture Figure United States Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022) Figure Mexico Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022) Figure Canada Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Injectable Anticoagulants Type and Applications Table Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors Table Genentech (Roche) Injectable Anticoagulants Type and Applications Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim Injectable Anticoagulants Type and Applications Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Injectable Anticoagulants Type and Applications Table Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table The Medicines Company Basic Information, Manufacturing Base and Competitors Table The Medicines Company Injectable Anticoagulants Type and Applications Table The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Aspen Basic Information, Manufacturing Base and Competitors Table Aspen Injectable Anticoagulants Type and Applications Table Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Otsuka Basic Information, Manufacturing Base and Competitors Table Otsuka Injectable Anticoagulants Type and Applications Table Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table North America Injectable Anticoagulants Sales by Manufacturer (2016-2017) Figure North America Injectable Anticoagulants Sales Market Share by Manufacturer in 2016 Figure North America Injectable Anticoagulants Sales Market Share by Manufacturer in 2017 Table North America Injectable Anticoagulants Revenue by Manufacturer (2016-2017) Figure North America Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016 Figure North America Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017 Table North America Injectable Anticoagulants Price by Manufacturers (2016-2017) Figure Top 3 Injectable Anticoagulants Manufacturer Market Share in 2016 Figure Top 3 Injectable Anticoagulants Manufacturer Market Share in 2017 Figure Top 5 Injectable Anticoagulants Manufacturer Market Share in 2016 Figure Top 5 Injectable Anticoagulants Manufacturer Market Share in 2017 Figure North America Injectable Anticoagulants Sales and Growth (2012-2017) Table North America Injectable Anticoagulants Sales by Countries (2012-2017) Table North America Injectable Anticoagulants Sales Market Share by Countries (2012-2017) Figure North America 2012 Injectable Anticoagulants Sales Market Share by Countries Figure North America 2016 Injectable Anticoagulants Sales Market Share by Countries Figure North America Injectable Anticoagulants Revenue and Growth (2012-2017) Table North America Injectable Anticoagulants Revenue by Countries (2012-2017) Table North America Injectable Anticoagulants Revenue Market Share by Countries (2012-2017) Table North America 2012 Injectable Anticoagulants Revenue Market Share by Countries Table North America 2016 Injectable Anticoagulants Revenue Market Share by Countries Table North America Injectable Anticoagulants Sales by Type (2012-2017) Table North America Injectable Anticoagulants Sales Share by Type (2012-2017) Table North America Injectable Anticoagulants Revenue by Type (2012-2017) Table North America Injectable Anticoagulants Revenue Share by Type (2012-2017) Figure North America Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017) Figure North America Low-molecular-weight Heparin (LMWH) Price (2012-2017) Figure North America Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017) Figure North America Direct Thrombin Inhibitor (DTI) Price (2012-2017) Figure North America Other Sales Growth (2012-2017) Figure North America Other Price (2012-2017) Table North America Injectable Anticoagulants Sales by Application (2012-2017) Table North America Injectable Anticoagulants Sales Share by Application (2012-2017) Figure North America VTE Sales Growth (2012-2017) Figure North America ACS/MI Sales Growth (2012-2017) Figure North America AF Sales Growth (2012-2017) Figure North America Other Sales Growth (2012-2017) Figure United States Injectable Anticoagulants Revenue and Growth (2012-2017) Figure United States Injectable Anticoagulants Sales and Growth (2012-2017) Table United States Injectable Anticoagulants Sales by Type (2012-2017) Table United States Injectable Anticoagulants Sales Market Share by Type (2012-2017) Table United States Injectable Anticoagulants Sales by Application (2012-2017) Table United States Injectable Anticoagulants Sales Market Share by Application (2012-2017) Table United States Injectable Anticoagulants Sales by Manufacturer (2016-2017) Figure United States Injectable Anticoagulants Sales Market Share by Manufacturer in 2016 Figure United States Injectable Anticoagulants Sales Market Share by Manufacturer in 2017 Table United States Injectable Anticoagulants Revenue by Manufacturer (2016-2017) Figure United States Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016 Figure United States Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017 Table United States Injectable Anticoagulants Export and Import (2012-2017) Figure Canada Injectable Anticoagulants Revenue and Growth (2012-2017) Figure Canada Injectable Anticoagulants Sales and Growth (2012-2017) Table Canada Injectable Anticoagulants Sales by Type (2012-2017) Table Canada Injectable Anticoagulants Sales Market Share by Type (2012-2017) Table Canada Injectable Anticoagulants Sales by Application (2012-2017) Table Canada Injectable Anticoagulants Sales Market Share by Application (2012-2017) Table Canada Injectable Anticoagulants Sales by Manufacturer (2016-2017) Figure Canada Injectable Anticoagulants Sales Market Share by Manufacturer in 2016 Figure Canada Injectable Anticoagulants Sales Market Share by Manufacturer in 2017 Table Canada Injectable Anticoagulants Revenue by Manufacturer (2016-2017) Figure Canada Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016 Figure Canada Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017 Table Canada Injectable Anticoagulants Export and Import (2012-2017) Figure Mexico Injectable Anticoagulants Revenue and Growth (2012-2017) Figure Mexico Injectable Anticoagulants Sales and Growth (2012-2017) Table Mexico Injectable Anticoagulants Sales by Type (2012-2017) Table Mexico Injectable Anticoagulants Sales Market Share by Type (2012-2017) Table Mexico Injectable Anticoagulants Sales by Application (2012-2017) Table Mexico Injectable Anticoagulants Sales Market Share by Application (2012-2017) Table Mexico Injectable Anticoagulants Sales by Manufacturer (2016-2017) Figure Mexico Injectable Anticoagulants Sales Market Share by Manufacturer in 2016 Figure Mexico Injectable Anticoagulants Sales Market Share by Manufacturer in 2017 Table Mexico Injectable Anticoagulants Revenue by Manufacturer (2016-2017) Figure Mexico Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016 Figure Mexico Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017 Table Mexico Injectable Anticoagulants Export and Import (2012-2017) Figure North America Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022) Table North America Injectable Anticoagulants Sales Forecast by Countries (2017-2022) Table North America Injectable Anticoagulants Market Share Forecast by Countries (2017-2022) Figure United States Injectable Anticoagulants Sales Forecast (2017-2022) Figure Canada Injectable Anticoagulants Sales Forecast (2017-2022) Figure Mexico Injectable Anticoagulants Sales Forecast (2017-2022) Table North America Injectable Anticoagulants Sales Forecast by Type (2017-2022) Table North America Injectable Anticoagulants Market Share Forecast by Type (2017-2022) Table North America Injectable Anticoagulants Sales Forecast by Application (2017-2022) Table North America Injectable Anticoagulants Market Share Forecast by Application (2017-2022) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Injectable Anticoagulants Figure Manufacturing Process Analysis of Injectable Anticoagulants Figure Injectable Anticoagulants Industrial Chain Analysis Table Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016 Table Major Buyers of Injectable Anticoagulants Table Distributors/Traders/ Dealers List

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Other Reports by GlobalInfoResearch

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Zirconia Ceramic Ball Market 2018 Forecast to 2023

This report studies zirconia ceramic ball mainly used for ceramic bearings and valves. The specifications demand of this kind of ball is much higher, as well as the price. In the market, there is another zirconia ceramic ball, which is commonly calle...

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Wood Pallet Market 2018 Forecast to 2023

"A pallet, sometimes inaccurately called a skid (a skid has no bottom deck boards), is a flat transport structure that supports goods in a stable fashion while being lifted by a forklift, pallet jack, front loader, work saver, or other jacking device...

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Website Builders Market 2018 Forecast to 2023

Website builders are tools that typically allow the construction of websites without manual code editing. Scope of the Report: This report focuses on the Website Builders in Global market, especially in North America, Europe and Asia-Pacific, Sou...

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Wallpaper Market 2018 Forecast to 2023

Wallpaper is a kind of material used to cover and decorate the interior walls of homes, offices, and other buildings; it is one aspect of interior decoration. Due to its variety of characteristics that other interior decoration materials cannot compa...

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Vitamin K2 Market 2018 Forecast to 2023

Vitamin K2 is the term for a group of compounds called ?menaquinones,? which can be found mainly in dairy products. All K vitamins are similar in structure, but differ in the length of the ?side chain?. The longer the side chain, the better effect an...

New Pharmaceuticals and Healthcare Reports